期刊文献+

冠心病患者ApoE基因多态性与血脂及颈动脉病变的相关性研究 被引量:1

Correlation between ApoE gene Polymorphism and Blood Lipid and Carotid Artery Disease in Patients with Coro⁃nary Heart Disease
下载PDF
导出
摘要 目的:探讨冠心病患者血脂及颈动脉病变与ApoE基因多态性的相关性。方法:选取2019年1月至2020年8月在我院行冠脉造影术证实冠心病且均行颈动脉超声检查诊断为颈动脉粥样硬化斑块形成者,所有患者均规律服用他汀类药物调脂治疗,共计280例,均行实时荧光定量PCR检测ApoE基因多态性,并根据ApoE基因型分为3组,E2表型组:基因型为E2/2+E2/3者;E3表型组:基因型为E3/3+E2/4者;E4表型组:基因型为E3/4+E4/4者。比较3组的一般临床资料、血脂、颈动脉内中膜厚度(IMT)、颈动脉斑块厚度及狭窄有无差异,并分析与ApoE基因多态性的相关性。结果:⑴在280例患者中,检测出6种基因型:E2/2(4例)、E2/3(39例)、E3/3(146例)、E2/4(19例)、E3/4(70例)、E4/4(2例);⑵3组间一般临床资料比较,差异均无统计学意义(P>0.05);⑶总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)水平在E4组中高于E2、E3组,差异有统计学意义(P<0.05);⑷IMT值、左右侧颈动脉斑块厚度在E4组中高于E2、E3组,差异均有统计学意义(P均<0.05);E4组中颈动脉狭窄发生率高于E2、E3组,差异有统计学意义(P<0.05),且E4表型组基因型存在时对应的颈动脉狭窄相关的ROC曲线提示曲线下面积为0.626(P<0.05)。结论:冠心病患者ApoE基因多态性与血脂、IMT、颈动脉斑块厚度及狭窄有相关性,E4表型组基因型存在时血脂、IMT值、颈动脉斑块厚度水平相对较高且增加颈动脉狭窄风险。 Objective To investigate the relationship between plasma lipids, carotid artery lesions and ApoE polymorphism in patients with coronary heart disease. Methods From January 2019 to August 2020, 280 patients with coronary artery disease confirmed by coronary angiography and diagnosed as carotid atherosclerotic plaque by carotid ultrasound in our hospital were selected. All patients were regularly treated with statins for lipid-lowering treatment. ApoE gene polymorphism was detected by real-time fluorescence quantitative PCR. They were divided into three groups according to ApoE genotype, E2 phenotype group: genotype E2/2 + E2/3;E3 phenotype group: genotype E3/3 + E2/4;E4 phenotype group: genotype E3/4 + E4/4. The general clinical data, blood lipid, carotid intima-media thickness(IMT), carotid plaque thickness and stenosis of the three groups were compared, and the correlation with ApoE gene polymorphism was analyzed. Results ⑴Six genotypes were detected in 280 patients: E2/2(4 cases), E2/3(39 cases), E3/3(146 cases), E2/4(19 cases), E3/4(70 cases), and E4/4(2 cases). ⑵There was no significant difference in clinical data among the 3 groups(P>0.05). ⑶The levels of TC, triglyceride and LDL-C in E4 group were significantly higher than those in E2 and E3 groups(P<0.05). ⑷The IMT and the thickness of left and right carotid plaque in E4 group were significantly higher than those in E2 and E3 groups(P<0.05). The incidence of carotid artery stenosis in E4 group was significantly higher than that in E2 and E3 group(P<0.05). When there were genotypes in E4 phenotype group, the corresponding ROC curve of carotid artery stenosis indicated that the area under the curve was 0.626(P<0.05). Conclusion ApoE gene polymorphism was correlated with blood lipid, IMT, carotid plaque thickness and stenosis in patients with coronary heart disease. When there were genotypes in E4 phenotype group, the levels of blood lipid, IMT value and carotid plaque thickness were relatively high, which increased the risk of carotid stenosis.
作者 唐俊 张斌强 徐先琳 李小雷 陈俊 闵新文 周心涛 陈继舜 TANG Jun;ZHANG Bin-qiang;XU Xian-lin;LI Xiao-lei;CHEN Jun;MIN Xin-wen;ZHOU Xin-tao;CHEN Ji-shun(Department of Cardiology,Sinopharm Dongfeng General Hospital,Hubei University of Medi-cine,Shiyan,Hubei 442008,China)
出处 《湖北医药学院学报》 CAS 2021年第5期486-490,共5页 Journal of Hubei University of Medicine
基金 国家自然科学基金项目(81872509) 湖北省自然科学基金项目(2019CFC841) 十堰市科技局引导性项目(19Y96) 国药东风总医院卓越计划青年人才项目(2021Q04) 湖北医药学院研究生科技创新项目(YC2021043)。
关键词 冠心病 APOE基因多态性 血脂 动脉粥样硬化 颈动脉狭窄 Coronary heart disease ApoE gene polymorphism Lipids Atherosclerosis Carotid artery stenosis
  • 相关文献

参考文献2

二级参考文献10

  • 1左小瑜,张敬一,孙燕.他汀类药物对心血管疾病的临床应用新进展及安全性[J].中华临床医学杂志,2005,6(5):53-54. 被引量:11
  • 2Lewichi M, Kotyla P, Jankiewicz - Ziobro K, et al. The role of adi- ponectin in atheroselerosis [ J ]. Pol Merkur Lekarski, 2006,20:494 - 496.
  • 3Lu Q, Doria A, Manson JE, et al. Adiponeetin genetic variability, plasma adiponectin and cardiovascular risk in patients with type 2 di- abetes [ J]. Diabetes ,2006,55 : 1512 - 1516.
  • 4Patel S, Flybbjerg A, Kozakoea M, et al. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness inde- pendent of plasma adiponeetin levels in healthy subjects [ J ]. Eur Heart J,2008,29:386 - 393.
  • 5Tajtakova M, Petrasova D, Petrovieova J, et al. Adiponeetin as a bi- omarker of clinical manifestation of metabolic syndrome [ J] . Endocr Regul, 2006,40 : 15 - 19.
  • 6Hoefle G, Muendlein A, Saely CH, et al. The - 11377 C > G prompter variant of the adiponectin gene, prevalence of coronary ath- eroselerosis, and incidence of vascular events in men [ J ]. Thomb Haemost, 2007,97:451 -454.
  • 7Gu HF. Biomarkers of adiponeetin: plasma protein variation and gen- pmie DNA polymorphisms [ J ]. Biomark Insights, 2009,4 : 123 - 128.
  • 8Laequemant C, Froguel P, Lobbans S, et al. The adiponeetin gene SNP + 45 is associated with coronary artery disease in type 2 ( non - insulin - dependent) diabetes mellitus [ J]. Diabet Med, 2004,21 : 776 - 781.
  • 9Woo JG, Dolan LM, Deka R, et al. Interaction beteen noncontigu- ous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin [J]. Diabetes, 2006,55:523 -529.
  • 10Qinxi Guo,Zilai Wang,Hongmei Li,Mary Wiese,Hui Zheng.APP physiological and pathophysiological functions: insights from animal models[J].Cell Research,2012,22(1):78-89. 被引量:5

共引文献14

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部